- Benzoyl peroxide
- Accession Number
- Small Molecule
Benzoyl peroxide (BPO) is an organic compound in the peroxide family. It consists of two benzoyl groups bridged by a peroxide link. It is one of the most important organic peroxides in terms of applications. In medicine, benzoyl peroxide is used as a topical treatment for acne, either in combination with antibiotics or as a single agent. These products are available over-the-counter or by prescription in gels, creams or liquids at concentrations of 2.5%, 5% or 10%. Benzoyl peroxide is also used for bleaching flour or hair, teeth whitening, for cross-linking polyester resins, and many other chemical uses. It is on the World Health Organization's List of Essential Medicines, the most important medications needed in a basic health system.
- Benzoyl benzenecarboperoxoate
- External IDs
- NSC-671 / NSC-675
- Prescription Products
Name Dosage Strength Route Labeller Marketing Start Marketing End 10 Benzagel Gel - 10% Gel 10 % Topical Dermik Laboratories 1998-12-01 2005-10-05 Acetoxyl 10 Gel Gel 10 % Topical Valeo Pharma Corp. 1978-12-31 2006-07-31 Acetoxyl 20acne Gel Gel 20 % Topical Stiefel Laboratories, Inc. 1978-12-31 1998-07-09 Benoxyl Lotion 20 % Topical Glaxosmithkline Inc 1970-12-31 2012-12-10 Benoxyl Lotion 10 % Topical Glaxosmithkline Inc 1976-12-31 2011-12-22 Benoxyl 10% Wash Liquid 10 % Topical Stiefel Laboratories, Inc. 1980-12-31 1998-07-09 Benzac Ac Gel 10% Gel 10 % Topical Galderma 1991-12-31 2016-08-04 Benzac W Wash Gel 10% Gel 10 % Topical Galderma 1991-12-31 Not applicable Benzac W10 Gel 10% USP Gel 10 % Topical Galderma 1980-12-31 2005-08-04 Benzagel 10 Gel 10% Gel 10 % Topical Rhone Poulenc Rorer 1993-12-31 1999-08-12
- Over the Counter Products
Name Dosage Strength Route Labeller Marketing Start Marketing End 2.5 Benzagel 2.5% Gel 2.5 % Topical Rhone Poulenc Rorer 1993-12-31 1997-08-13 2.5 Benzagel 2.5% Acne Gel Gel 2.5 % Topical Novartis 1996-09-29 1999-07-21 2.5 Benzagel Acne Lotion 2.5% Lotion 2.5 % Topical Rhone Poulenc Rorer 1993-12-31 1997-08-13 2.5 Benzagel Acne Lotion 2.5% Lotion 2.5 % Topical Novartis 1996-09-30 1999-07-21 3 Step Acne System Well at Walgreens Kit Walgreens 2014-07-15 Not applicable 5 Benzagel Liquid Acne Soap 5% Liquid 5 % Topical Rhone Poulenc Rorer 1993-12-31 1996-09-09 5 Benzagel Lotion 5% Lotion 5 % Topical Rhone Poulenc Rorer 1993-12-31 1997-08-13 5% BP Face and Body Wash Liquid 50 mg/mL Topical Cos Medical Technologies 2015-11-04 Not applicable AB Skincare Acne Spot Treatment Cream 28.3 g/100g Topical Norris Ltd 2017-10-09 Not applicable Acetoxyl 2.5 Gel Gel 2.5 % Topical Valeo Pharma Corp. 1978-12-31 2011-08-02
- Unapproved/Other Products
Name Dosage Strength Route Labeller Marketing Start Marketing End BenzEFoam Aerosol, foam 5.3 g/100g Topical Onset Dermatologics, LLC 2009-09-18 Not applicable BenzEFoam Ultra Aerosol, foam 9.8 g/100g Topical Onset Dermatologics, LLC 2011-03-04 Not applicable BenzePrO Creamy Wash Soap 7 g/100g Topical Pru Gen Pharmaceuticals 2015-07-01 Not applicable Benzoyl Peroxide Liquid 2.5 g/100g Topical Perrigo New York Inc. 2008-02-08 2017-07-27 Benzoyl Peroxide Liquid 10 g/100g Topical Perrigo New York Inc. 2008-05-19 2017-01-18 Benzoyl Peroxide aqueous base Gel 2.5 g/100g Topical Perrigo New York Inc. 2008-09-24 2017-01-18 Benzoyl peroxide emollient Aerosol, foam 5.3 g/100g Topical Metacon Labs 2011-04-01 2016-03-31 Benzoyl peroxide short contact Aerosol, foam 9.8 g/100g Topical Metacon Labs 2011-04-01 2017-02-28 BPO 3 Foaming Cloth 3.2 g/100g Topical Acella Pharmaceuticals, LLC 2010-08-18 2017-08-17 BPO 6 Foaming Cloth 3.2 g/100g Topical Acella Pharmaceuticals, LLC 2010-08-18 Not applicable
- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Acanya Benzoyl peroxide (25 mg/g) + Clindamycin phosphate (10 mg/g) Gel Topical Valent Pharmaceuticals North America 2010-07-26 Not applicable Acne Clearning Treatment Face Benzoyl peroxide (.006 mg/.024mg) + Salicylic acid (.0048 mg/.024mg) + Sulfur (.012 mg/.024mg) Liquid Topical Care Pluss Pharma S.A. De C.V. 2012-08-06 Not applicable Acne Treatment System Benzoyl peroxide (5 %) + Salicylic acid (2 %) Kit; Liquid; Lotion Topical Vivier Canada Incorporated 2013-11-15 Not applicable Acne Treatment System Benzoyl peroxide + Salicylic acid Kit Vivier Pharma 2017-07-19 Not applicable Active Anti-acne Treatment Kit Benzoyl peroxide (2.5 %) + Benzoyl peroxide (2.5 %) Kit; Lotion Topical Fruit Of The Earth, Inc. 2015-12-10 Not applicable Active Anti-acne Treatment Kit Benzoyl peroxide (2.5 %) + Benzoyl peroxide (2.5 %) Kit; Lotion Topical Fruit Of The Earth, Inc. 2015-12-10 Not applicable Adapalene and Benzoyl Peroxide Benzoyl peroxide (25 mg/g) + Adapalene (1 mg/g) Gel Topical Prasco, Laboratories 2017-08-03 Not applicable Adapalene and Benzoyl Peroxide Benzoyl peroxide (25 mg/g) + Adapalene (1 mg/g) Gel Topical Actavis Pharma Company 2017-07-27 Not applicable Advantage Acne Control Kit Benzoyl peroxide (2.5 %) + Benzoyl peroxide (5 %) Gel; Kit; Lotion Topical Johnson & Johnson 2017-01-30 Not applicable Advantage Acne Control Kit Benzoyl peroxide (2.5 %) + Benzoyl peroxide (5 %) Gel; Kit; Lotion Topical Johnson & Johnson 2017-01-30 Not applicable
- CAS number
- Average: 242.2268
- Chemical Formula
- InChI Key
- IUPAC Name
- benzoyl benzenecarboperoxoate
Benzoyl peroxide is indicated for the treatment of mild to moderate acne vulgaris and rosacea. Combined with other agents, it may be used in the treatment of more severe acne.
- Structured Indications
Benzoyl peroxide acts as an antibacterial, irritant, keratolytic, comedolytic, and anti-inflammatory agent when applied topically to the human epithelium.
- Mechanism of action
Benzoyl peroxide decomposes to release oxygen after topical application. This oxygen acts as a bactericidal agent towards Proprionibacterium acnes, the bacteria present in acne vulgaris. Benzoyl peroxide also increases the turnover rate of epithelial cells, thereby peeling the skin and promoting the resolution of comedones.
Benzoyl peroxide is absorbed percutaneously into the dermal layer of the epithelium. It is then metabolized to benzoic acid which can be absorbed systemically. There is no systemic absorption of benzoyl peroxide itself.
- Volume of distribution
Benzoyl peroxide is not absorbed or distributed systemically after topical application.
- Protein binding
Benzoyl peroxide does not undergo protein binding as it is does not enter systemic circulation after topical application.
Benzoyl peroxide undergoes metabolism by keratinocytes in the epidermis. Initially, the peroxide bond is cleaved to form benzoyloxyl radicals. It is thought this reaction may be copper-catalyzed. The benzoyloxyl radicals may then fragment to form carbon dioxide and a phenyl radical. Alternatively, the radicals may gain a hydrogen atom from biomolecules forming the more stable and primary metabolite, benzoic acid.
- Route of elimination
Renal clearance of the primary metabolite, benzoic acid, is rapid and thought to preclude hepatic conjugation.
- Half life
Benzoyl peroxide is not absorbed into systemic circulation after topical application. Further studies are needed on its half life within the epithelium.
Benzoyl peroxide is not absorbed into systemic circulation after topical application. Its primary metabolite, benzoic acid, is cleared rapidly via renal excretion and hepatic conjugation is thought to be bypassed.
There is no evidence to support carcinogenicity in humans. Benzoyl peroxide may cause contact hypersensitivity, stinging and burning sensations when applied topically. It should not be applied under occlusive dressings due to risk of sensitization. During processing and formulation, exposure to concentrations higher than 12.2 mg/cu may cause irritation to the nose and/or throat.
- Affected organisms
- Propionibacterium acnes
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
- Drug Interactions
Drug Interaction Drug group Dapsone The risk or severity of adverse effects can be increased when Benzoyl peroxide is combined with Dapsone. Approved, Investigational
- Food Interactions
- Not Available
- Synthesis Reference
- Zenz, C. Occupational Medicine - Principles and Practical Applications. 2nd ed. St. Louis, MO: Mosby-Yearbook Inc.; 1988: 712.
- Budavari, S. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Whitehouse Station, NJ: Merck and Co., Inc.; 1996: 187.
- Ashford, RD. Ashford's Dictionary of Industrial Chemicals. London, England: Wavelength Publications Ltd.; 1994: 119.
- General References
- Bojar RA, Cunliffe WJ, Holland KT: The short-term treatment of acne vulgaris with benzoyl peroxide: effects on the surface and follicular cutaneous microflora. Br J Dermatol. 1995 Feb;132(2):204-8. [PubMed:7888356]
- Kawashima M, Nagare T, Katsuramaki T: Open-label, randomized, multicenter, phase III study to evaluate the safety and efficacy of benzoyl peroxide gel in long-term use in patients with acne vulgaris: A secondary publication. J Dermatol. 2017 Feb 2. doi: 10.1111/1346-8138.13741. [PubMed:28150367]
- Francis NA, Entwistle K, Santer M, Layton AM, Eady EA, Butler CC: The management of acne vulgaris in primary care: a cohort study of consulting and prescribing patterns using the Clinical Practice Research Datalink. Br J Dermatol. 2017 Jan;176(1):107-115. doi: 10.1111/bjd.15081. Epub 2016 Dec 27. [PubMed:27716910]
- Rosamilia LL: Over-the-counter treatments for acne and rosacea. Semin Cutan Med Surg. 2016 Jun;35(2):87-95. doi: 10.12788/j.sder.2016.026. [PubMed:27416314]
- Yeung D, Nacht S, Bucks D, Maibach HI: Benzoyl peroxide: percutaneous penetration and metabolic disposition. II. Effect of concentration. J Am Acad Dermatol. 1983 Dec;9(6):920-4. [PubMed:6643790]
- Nacht S, Yeung D, Beasley JN Jr, Anjo MD, Maibach HI: Benzoyl peroxide: percutaneous penetration and metabolic disposition. J Am Acad Dermatol. 1981 Jan;4(1):31-7. [PubMed:7204686]
- Swauger JE, Dolan PM, Zweier JL, Kuppusamy P, Kensler TW: Role of the benzoyloxyl radical in DNA damage mediated by benzoyl peroxide. Chem Res Toxicol. 1991 Mar-Apr;4(2):223-8. [PubMed:1782351]
- External Links
- ATC Codes
- D10AE51 — Benzoyl peroxide, combinations
- D10AE — Peroxides
- D10A — ANTI-ACNE PREPARATIONS FOR TOPICAL USE
- D10 — ANTI-ACNE PREPARATIONS
- D — DERMATOLOGICALS
- AHFS Codes
- 84:28.00 — Keratolytic Agents
- Download (37.4 KB)
- Clinical Trials
Phase Status Purpose Conditions Count 0 Recruiting Treatment Osteomyelitis 1 1 Completed Prevention Acne Vulgaris 1 1 Completed Treatment Acne Vulgaris 6 2 Completed Treatment Acne Vulgaris 1 2 Enrolling by Invitation Prevention Surgical Site Infections 1 3 Completed Treatment Acne 4 3 Completed Treatment Acne Vulgaris 11 3 Not Yet Recruiting Treatment Acne Vulgaris 1 3 Unknown Status Treatment Acne Vulgaris 2 4 Active Not Recruiting Prevention Acne Vulgaris / Atrophic Acne Scars 1 4 Completed Not Available Acne Vulgaris 1 4 Completed Not Available P Acnes Colonization 1 4 Completed Treatment Acne 1 4 Completed Treatment Acne Vulgaris 19 4 Completed Treatment Skin Diseases 1 4 Unknown Status Treatment Acne Vulgaris 1 4 Unknown Status Treatment Treatment of Acne Vulgaris Grade II in a Short Period of Time 1 Not Available Completed Not Available Acne 1 Not Available Completed Not Available Acne Vulgaris 1 Not Available Completed Treatment Acne Vulgaris 8 Not Available Recruiting Prevention Shoulder Infection 1
- Not Available
- Not Available
- Dosage forms
Form Route Strength Cream Topical 28.3 g/100g Liquid Topical Gel Topical 5 mL/100mL Shampoo, suspension Topical 25 mg/mL Lotion Topical 100 mg/1000mL Lotion Topical 50 mg/1000mL Cream Topical 10 g/100mL Lotion Topical 30 mg/g Solution Topical 5.0 % Gel Topical 1 mg/g Gel Topical 3.5 g/100mL Kit; liquid; lotion Topical Cream Topical 25 mg/g Liquid Topical 4.25 g/170g Cream Topical 3.4 g/136g Liquid Topical 25 mg/mL Cream Topical 50 mg/g Lotion Topical 10 mL/100mL Cream Topical 100 mg/g Kit; lotion Topical Liquid, extended release Topical 44 mg/mL Gel; kit; lotion Topical Aerosol, foam Topical 2.5 g/100g Cream Topical 5.5 g/100mL Cream Topical .026 mg/mg Cream Topical 1.4 g/28g Lotion Topical 5 g/100mL Lotion Topical 20 % Solution Topical 2.6 g/100mL Gel Topical 2.6 % Gel Topical 10 % Gel Topical 5 % Liquid Topical 5 % Gel Topical 2.5 % Kit Aerosol, foam Topical 3.18 g/60g Aerosol, foam Topical 9.8 g/100g Soap Topical 7 g/100g Lotion Topical 3 g/100mL Aerosol, foam Topical 53 mg/g Aerosol, foam Topical 98 mg/g Gel Topical 100 mg/g Gel Topical 50 mg/g Kit Topical Liquid Topical 10 g/100g Liquid Topical 2.5 g/100g Liquid Topical 30 mg/mL Liquid Topical 5 g/100g Liquid Topical 60 mg/mL Liquid Topical 90 mg/mL Gel Topical 50 mg/1000mg Solution Topical 2.5 % Gel Topical 2.5 g/100g Gel Topical 35 mg/g Aerosol, foam Topical 5.3 g/100g Cream Topical 3.29 g/56g Cream Topical 2.5 mL/100mL Gel Topical 5 g/100mL Gel Topical 5.0 % Emulsion Topical 42.5 mg/mL Lotion Topical 40 mg/g Gel Topical 55 mg/g Emulsion Topical 100 mg/g Emulsion Topical 25 mg/g Emulsion Topical 50 mg/g Emulsion Topical 52.5 mg/g Emulsion Topical 70 mg/mL Gel Topical 4 mg/100mg Gel Topical 8 mg/100mg Cloth Topical 3.2 g/100g Solution Topical 5 % Cloth Topical 9 g/100g Lotion Topical 5 mL/100mL Cream Topical 1.125 g/15g Gel Topical 5.00 % Aerosol Topical 2.5 % Cream Topical 5.0 % Lotion Topical 5 % Liquid Topical 5.57 mg/g Gel Topical 25 mg/g Liquid Topical .006 mg/.024mg Lotion Topical Liquid Topical 3 % Cream Topical 30 mg/mL Liquid Topical 3.7 % Lotion Topical 3.5 % Liquid Topical 3.5 % Cream Topical 5 % Cloth Topical Kit; lotion Topical 5 % Lotion Topical 2.5 % Cream Topical 25 mg/mL Cream Topical .8 mg/29.6mg Gel Topical 61.62 mg/mL Cream Topical 4 g/100g Soap Topical 100 mg/g Cream Topical 104 mg/10g Gel Topical 20 % Solution Topical 10 mg/mL Solution Topical 10 mg/g Solution Topical 5 mg/mL Solution Topical 5 mg/g Lotion Topical 10 % Solution Topical 5 g/100mL Lotion Topical 2.5 g/100mL Gel; lotion Topical 2.5 % Cloth Topical 2.5 % Liquid, extended release Topical 4.5 mg/100mL Liquid Topical .1 mg/g Gel Topical 135 mg/g Gel Topical 25 mg/mL Liquid Topical 3 g/120g Lotion Topical 1.5 g/60g Lotion Topical 25 mg/mL Cream Topical 10 g/100g Cream Topical 4 % Gel Topical 5.6 g/56g Gel Topical 3 mL/60mL Lotion Topical 45 mg/mL Gel Topical 51.9 mg/100mL Cream Topical 10 % Cream Topical 20 % Cream Topical 2.5 % Cream Topical 5.3 g/100g Gel Topical 10 g/100mL Suspension Topical 10 g/100g Lotion Topical 55 mg/mL Lotion Topical 2.2 mg/40mL Cream Topical 1 g/100g Cream Topical 5 g/100mL Cream Topical 5 g/100g Gel Topical Kit Topical Paste Topical 5 % Gel Topical 3.5 % Gel Topical 35 mg/mL Lotion Topical 35 mg/mL Cream Topical 37 mg/mL Suspension Topical 37 mg/mL Jelly Topical 2.5 % Cream Topical 2.5 mg/g Lotion Topical .05 mL/mL Lotion Topical 5.0 % Gel Topical 7 mg/g Solution Topical 2.5 g/100mL Cream Topical 2.5 g/100g Lotion Topical 3.0 % Lotion Topical 100 mg/g Lotion Topical 50 mg/g Ointment Topical 5 % Liquid Topical 100 mg/mL Liquid Topical 50 mg/mL Swab Topical 25 mg/1 Stick Topical 50 mg/g Cream Topical 100 mg/mL Cream Topical 50 mg/mL Cloth Topical 70 mg/g Cloth Topical 42.5 mg/g Cream Topical 146.7 mg/g Cream Topical 30 mg/g Cream Topical 58.7 mg/g Soap Topical .5 g/10g Soap Topical 1 g/10g Soap Topical 11.3 g/1 Soap Topical 5.65 g/1 Soap Topical 10 % Soap Topical 5 % Liquid Topical 4 % Liquid Topical 10 % Kit; lotion; solution Topical Gel Topical 10 g/100g Gel Topical 5 g/100g Lotion Topical 5 g/100g Solution Topical .063 mg/2.5mL Lotion Topical .063 mg/2.5mL Lotion Topical 70 mg/mL Gel; kit Topical Cream Topical .06 g/g Lotion Topical 7 mg/100mL Cream Topical 7 mg/100mL Gel Topical 2.5 mg/100mL Cream Topical .025 g/1000mL Cream Topical .25 g/1000mL Gel Topical 2.5 g/100mL Lotion Topical 2.5 mL/100mL Gel Topical 2.5 mL/100mL Lotion Topical 2.5 mg/100mL Lotion Topical 3 % Cream Topical 52.5 mg/mL Liquid Topical 7.5 mL/100mL Cream Topical 2.95 mL/59mL Aerosol, foam Topical 55 mg/g Aerosol, foam Topical 95 mg/g Lotion Topical 2.50 % Cream; gel; kit; lotion Topical 2.5 % Gel Topical 100 mg/mL Gel Topical 50 mg/mL Lotion Topical 100 mg/mL Lotion Topical 50 mg/mL Kit Liquid Topical 2.5 % Paste Topical 3.5 % Swab Topical 25 mg/mL Lotion Topical 25 mg/g Gel Topical 4 % Gel Topical 8 % Gel Topical 3 % Lotion Topical 4 % Gel; kit; paste Topical Cream Topical Lotion Topical 2.5 g/100g Soap Topical 60 mg/g Swab Topical 2.75 mg/1 Gel Topical 8.5 mg/100g Ointment Topical 100 mg/g
- Not Available
Patent Number Pediatric Extension Approved Expires (estimated) US8909305 No 2002-12-23 2022-12-23 US8703820 No 2003-03-12 2023-03-12 US7964202 No 2004-09-01 2024-09-01 US8071644 No 2007-07-18 2027-07-18 US8080537 No 2007-07-18 2027-07-18 US8105618 No 2002-12-23 2022-12-23 US8129362 No 2007-07-18 2027-07-18 US8445543 No 2007-07-12 2027-07-12 US8809305 No 2002-12-23 2022-12-23 US8936800 No 2002-12-23 2022-12-23 US8241649 No 2002-12-23 2022-12-23 US7820186 No 2005-11-23 2025-11-23 US8288434 No 2009-08-05 2029-08-05 US8663699 No 2009-06-03 2029-06-03 US8895070 No 2009-06-03 2029-06-03 US9078870 No 2009-06-03 2029-06-03 US8785420 No 2002-12-23 2022-12-23 US8729127 No 2003-03-12 2023-03-12 US9504704 No 2009-06-03 2029-06-03 US9561208 No 2009-06-03 2029-06-03 US9381179 No 2003-03-12 2023-03-12 US9387187 No 2003-03-12 2023-03-12
- Experimental Properties
Property Value Source melting point (°C) 103 - 106 Budavari, S. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Whitehouse Station, NJ: Merck and Co., Inc.; 1996: 187. boiling point (°C) Decomposes explosively above melting point. Does not reach boiling point. United States Department of Labor. OSHA Occupational Chemical Database. Occupational Safety and Health Administration website. https://www.osha.gov/chemicaldata/chemResult.html?RecNo=748. Accessed February 22, 2017. water solubility <1% United States Department of Labor. OSHA Occupational Chemical Database. Occupational Safety and Health Administration website. https://www.osha.gov/chemicaldata/chemResult.html?RecNo=748. Accessed February 22, 2017.
- Predicted Properties
Property Value Source Water Solubility 0.0294 mg/mL ALOGPS logP 2.75 ALOGPS logP 3.95 ChemAxon logS -3.9 ALOGPS pKa (Strongest Basic) -7.2 ChemAxon Physiological Charge 0 ChemAxon Hydrogen Acceptor Count 2 ChemAxon Hydrogen Donor Count 0 ChemAxon Polar Surface Area 52.6 Å2 ChemAxon Rotatable Bond Count 5 ChemAxon Refractivity 64.77 m3·mol-1 ChemAxon Polarizability 24.16 Å3 ChemAxon Number of Rings 2 ChemAxon Bioavailability 1 ChemAxon Rule of Five Yes ChemAxon Ghose Filter Yes ChemAxon Veber's Rule No ChemAxon MDDR-like Rule No ChemAxon
- Predicted ADMET features
- Not Available
- Mass Spec (NIST)
- Not Available
Spectrum Spectrum Type Splash Key Predicted GC-MS Spectrum - GC-MS Predicted GC-MS Not Available Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available
- This compound belongs to the class of organic compounds known as benzoyl peroxides. These are organic compounds containing two benzoyl groups O-linked to each other via a peroxide group. Their skeleton has the general formula [C6H5C(O)]2O2.
- Organic compounds
- Super Class
- Benzene and substituted derivatives
- Sub Class
- Benzoyl peroxides
- Direct Parent
- Benzoyl peroxides
- Alternative Parents
- Peroxybenzoic acids and derivatives / Benzoyl derivatives / Dicarboxylic acids and derivatives / Peroxycarboxylic acids and derivatives / Carboxylic acid salts / Organooxygen compounds / Organic salts / Organic oxides / Hydrocarbon derivatives
- Benzoyl peroxide / Peroxybenzoate / Benzoic acid or derivatives / Benzoyl / Dicarboxylic acid or derivatives / Peroxycarboxylic acid or derivatives / Carboxylic acid salt / Carboxylic acid derivative / Organic oxygen compound / Organic oxide
- Molecular Framework
- Aromatic homomonocyclic compounds
- External Descriptors
- carbonyl compound (CHEBI:82405)
Drug created on September 16, 2015 12:04 / Updated on November 19, 2017 20:34